In case you missed it, Episode 1 in our podcast series, “PARADIGM PERCEPTION SHIFT in Medical Device Development: the INNOVATION ROADMAP™,” launched last week.
In the first episode of this series, we provided an overview of the INNOVATION ROADMAP™ as applied to Medical Device Development. We “opened up” the map and explained the three key stops along this journey.
Stay tuned for Episode 2 coming next week as we dive into the first Stop on the INNOVATION ROADMAP™, Market Exploration & Discovering Opportunities. The FDA-QSR & ISO-13485 guidance recognizes this as a quintessential activity for any business to perform, making it known that regulatory controls such as Design Controls & Risk Management do not have to be performed at this point. The FDA understands the importance of a company needing to explore opportunities first.
MIDI at LSI
MIDI is enjoying the opportunity to engage with fellow MedTech Innovators, Investors, and Thought Leaders at LSI – Life Science Intelligence™ Summit happening now. So far, it’s been a wonderful event and very well attended.
If you’re also attending, MIDI’s co-founder, Gregory Montalbano can meet with you to discuss our process and expertise for advancing your healthcare technology and product development Strategy, Design, Innovation, Engineering, and Commercialization efficiently and at scale.
Want to meet Greg at LSI? You can contact him directly or through the LSI Portal. gregm@midipd.com
We do not share your information with third parties
